Health Care & Life Sciences » Pharmaceuticals | Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC | Balance Sheet

Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
106
185
402
147
187
233
Total Accounts Receivable
243
261
307
608
577
603
Inventories
167
175
170
371
361
415
Other Current Assets
26
29
43
45
39
59
Total Current Assets
542
650
923
1,172
1,164
1,310
Net Property, Plant & Equipment
267
330
344
784
612
683
Total Investments and Advances
14
12
6
11
16
30
Long-Term Note Receivable
-
-
-
2
3
-
Intangible Assets
270
386
412
1,391
580
601
Other Assets
19
24
30
31
30
24
Total Assets
1,165
1,444
1,762
3,531
2,505
2,746
ST Debt & Current Portion LT Debt
97
253
79
95
64
Accounts Payable
72
83
94
139
161
Income Tax Payable
42
42
51
91
61
Other Current Liabilities
143
162
178
418
303
Total Current Liabilities
354
539
402
743
589
Long-Term Debt
170
108
415
600
510
Deferred Taxes
36
27
33
127
64
Other Liabilities
1
1
14
224
240
Total Liabilities
540
664
845
1,580
1,375
Common Equity (Total)
614
768
907
1,939
1,119
Total Shareholders' Equity
614
768
907
1,939
1,119
Total Equity
624
780
917
1,951
1,130
Liabilities & Shareholders' Equity
1,165
1,444
1,762
3,531
2,505
Accumulated Minority Interest
10
12
10
12
10

About Hikma Pharmaceuticals

View Profile
Address
1 New Burlington Place
London Greater London W1S 2HR
United Kingdom
Employees -
Website http://hikma.com
Updated 07/08/2019
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products.